Myocardial Ischemia

Showing NaN - NaN of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Coronary Artery Disease, Coronary Disease, Myocardial Ischemia Trial in United States (Scoreflex NC Scoring PTCA catheter)

Completed
  • Coronary Artery Disease
  • +5 more
  • Scoreflex NC Scoring PTCA catheter
  • Gainesville, Florida
  • +8 more
Jul 19, 2021

Myocardial Ischemia Trial in United States (CLBS14 (low-dose), CLBS14 (high-dose), injection)

Completed
  • Myocardial Ischemia
  • CLBS14 (low-dose)
  • +2 more
  • Birmingham, Alabama
  • +25 more
Jan 8, 2021

Coronary Artery Disease, Atherosclerosis, Myocardial Ischemia Trial in United States (2.25 mm XIENCE V® Everolimus Eluting

Terminated
  • Coronary Artery Disease
  • +2 more
  • 2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System
  • Scottsdale, Arizona
  • +33 more
Apr 29, 2019

ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)

Completed
  • Myocardial Ischemia
    • Birmingham, Alabama
    • +22 more
    Nov 27, 2018

    Coronary Artery Disease, Coronary Disease, Myocardial Ischemia Trial in United States (Sapphire II PRO)

    Completed
    • Coronary Artery Disease
    • +5 more
    • Sapphire II PRO
    • Miami, Florida
    • +3 more
    Apr 10, 2018

    Chronic Total Occlusion of Coronary Artery, Vascular Disease, Myocardial Ischemia Trial in United States ( + aspirin,

    Completed
    • Chronic Total Occlusion of Coronary Artery
    • +6 more
    • placebo + aspirin
    • +2 more
    • Birmingham, Alabama
    • +143 more
    May 12, 2016

    Myocardial Ischemia, Coronary Artery Stenosis, Coronary Disease Trial in Australia, United States (Core size Xience Prime,

    Completed
    • Myocardial Ischemia
    • +4 more
    • Core size Xience Prime
    • Xience Prime Long Lesion (LL)
    • Fairhope, Alabama
    • +61 more
    May 12, 2015

    Acute Coronary Syndrome, Myocardial Infarction, Myocardial Ischemia Trial in Worldwide (Rivaroxaban 2.5 mg, Rivaroxaban 5 mg,

    Completed
    • Acute Coronary Syndrome
    • +3 more
    • Rivaroxaban 2.5 mg
    • +3 more
    • Birmingham, Alabama
    • +583 more
    Aug 26, 2014

    Stents, Coronary Artery Disease, Total Coronary Occlusion Trial in United States (XIENCE V® Everolimus Eluting Coronary Stent,

    Completed
    • Stents
    • +7 more
    • XIENCE V® Everolimus Eluting Coronary Stent
    • TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent
    • Birmingham, Alabama
    • +64 more
    Nov 16, 2011

    Saphenous Vein Graft Disease, Myocardial Ischemia, Embolism Trial in United States (FiberNet EPS used during SVG intervention.)

    Completed
    • Saphenous Vein Graft Disease
    • +2 more
    • FiberNet EPS used during SVG intervention.
    • Ocala, Florida
    • +5 more
    Aug 17, 2009

    Myocardial Ischemia, Coronary Arteriosclerosis, Aortic Valve Insufficiency Trial in United States (TP10)

    Completed
    • Myocardial Ischemia
    • +3 more
    • San Francisco, California
    • +17 more
    Jul 19, 2007